Reply to: Frequent self-assessments in ALS clinical trials: Worthwhile or an unnecessary burden?
Seward B RutkovePushpa NarayanaswamiVisar BerishaJulie LissShira HahnKerisa SheltonKristin QiSarbesh PandeyaJeremy M ShefnerPublished in: Annals of clinical and translational neurology (2020)